ETFs positioned on Boston Scientific Corporation

Name Weight AuM 1st Jan change Investor Rating
2.26% 0 M€ +15.09% -
1.98% 0 M€ +2.21% -
1.75% 33 M€ +2.58% -
1.23% 0 M€ -1.17% -
1.03% 0 M€ +6.14% -
0.78% 395 M€ +3.05% -
0.72% 457 M€ +3.42% -
0.72% 44 M€ +3.22% -
0.66% 0 M€ -.--% -
0.62% 0 M€ -72.95% -
0.47% 864 M€ +7.29%
0.38% 29 M€ +3.34% -
0.37% 3 M€ -.--%
0.37% 0 M€ +16.85% -
0.35% 0 M€ -.--% -
0.28% 0 M€ +0.04% -
0.27% 34 M€ +2.67% -
0.26% 0 M€ -.--% -
0.26% 0 M€ -.--% -
0.22% 24 M€ -1.99% -
0.22% 0 M€ -.--% -
0.22% 0 M€ -.--% -
0.22% 0 M€ +23.54% -
0.21% 0 M€ +17.98% -
0.21% 192 M€ +2.21% -
0.21% 37,736 M€ +0.24% -
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Employees
48,000
More about the company
Trading Rating
Investor Rating
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
105.77USD
Average target price
115.49USD
Spread / Average Target
+9.19%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BSX Stock
  4. ETFs Boston Scientific Corporation